Live Breaking News & Updates on Viatris

Stay informed with the latest breaking news from Viatris on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Viatris and stay connected to the pulse of your community

LinkedIn names TCS as top tech company to work for in India: Here's the complete list

TECH NEWS : LinkedIn announces TCS, Accenture, Cognizant as top workplaces in India. Lentra, MakeMyTrip, Nykaa shine. Career development, upskilling, and employee

India , Hauser-group , Morgan-stanley , Linkedin , Deloitte , Accenture , Intel-corporation , Tata-consultancy-services , Makemytrip , Top-companies , Pepsico

Pharma deal could reduce choice and lead to higher prices for HRT treatments | Competition & Markets Authority

Following its Phase 1 investigation, the CMA has found that Theramex's proposed purchase of Femoston and Duphaston could reduce competition and choice for hormone replacement therapy treatments.

United-kingdom , United-states , Sorcha-ocarroll , Theramex-viatris , Senior-director , Theramex , Cma , Hrt , Viatris , Uk , Femoston , Phase

Teva, Viatris win new chance to challenge J&J schizophrenia drug patent

(Reuters) -Teva Pharmaceutical and Viatris convinced a U.S. appeals court on Monday to revive their challenges to a patent covering a blockbuster Johnson & Johnson schizophrenia drug, giving them a new chance to clear a path to launch cheaper generic versions of the medicine. The U.S. Court of Appeals for the Federal Circuit said that the last remaining J&J patent covering its Invega Sustenna may be invalid, sending the case back for a New Jersey federal court to reconsider. A J&J spokesperson said the company will "continue defending the intellectual property of Invega Sustenna."

Washington , United-states , New-jersey , Alexia-garamfalvi , Blake-brittain , Claire-cecchi , Invega-sustenna , Reuters , Johnson , Teva-pharmaceutical , Us-court , Federal-circuit

2 Dirt Cheap Dividend Stocks to Buy and Hold

These companies aren't popular on the market right now, but income investors will like them.

Switzerland , Pfizer , Motley-fool-stock-advisor , Stock-advisor , Viatris , Ividend-stocks , Fizer ,

Viatris, Cooper Consumer Health Sign Transaction Deal

By Sabela Ojea Viatris has signed a transaction agreement with Cooper Consumer Health, according to a Securities and Exchange Commission filing on Tuesday....

France , Sabela-ojea , Exchange-commission , Cooper-consumer-health , Article-normal , Pharmaceuticals , Healthcare-life-sciences , Generic-biosimilar-drugs , Corporate-industrial-news , Synd , Viatris , Vtrs

Theravance Biopharma in Cooperation Agreement With Irenic Capital

By Josh Beckerman Theravance Biopharma reached a cooperation agreement with stockholder Irenic Capital Management, which in February criticized the company's...

Josh-beckerman , Theravance-biopharma , Irenic-capital-management , Jeremy-grant , Harbor-ridge , Irenic-capital , Article-normal , Biotechnology-services , Pharmaceuticals , Financial-investment-services , Portfolio-fund-asset-management

Biocon Biologics: Biocon subsidiary grants distribution of biosimilar to Sandoz in Japan

India Business News: Biocon Biologics, a subsidiary of Biocon has signed a distribution agreement with Sandoz, granting the company exclusive rights to promote, sell and d

Japan , Biocon-biologics , Biocon , Fujifilm-kyowa-kirin-biologics , Business-news , Viatris , Sandoz , Adalimumab-bs ,

Biocon Biologics completes integration of Viatris' biosimilar business in 120 countries

The company said over 10 emerging markets along with Japan, Australia and New Zealand have transitioned in this final phase of the integration of the biosimilars business acquired from Viatris. With the completion of this significant milestone, Biocon Biologics is now a fully integrated ‘lab to market biosimilars company committed to serving millions of patients across the globe.

Business-news , Breaking-news-events , Latest-news-updates , Economic-times , Economic-times-news-app , Daily-market-updates , Live-business , Biocon , Biocon-biologics , Biosimilar-business , Viatris

Vertex Stock Is Jumping as Data Raise Hope for a Pain Pill Blockbuster

Vertex disclosed promising test results for a drug that could offer an alternative to opioids.

Michael-yee , Josh-nathan-kazis , Reshma-kewalramani , Viatris-lyrica , Christopher-raymond , Stuart-arbuckle , Raymond-james , Vertex-oxford-lab-courtesy-pharmaceuticals-incorporated , Vertex-oxford-lab , Courtesy-vertex-pharmaceuticals-incorporated , Wall-street , Article-normal

Biocon Biologics Successfully Completes Integration of Viatris' Biosimilar Business in 31 Countries in Europe

Biocon Biologics personnel working at the insulin devices manufacturing facility in Bengaluru, India. Biocon Biologics personnel working at the insulin devices manufacturing facility in Bengaluru, India. BENGALURU, India, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the integration of the Viatris’ biosimilars business in 31 European countries has been successfully completed. Following the acquisitio

United-kingdom , Australia , Finland , Sweden , Spain , Lithuania , France , Malta , Japan , Poland , Portugal , Slovenia